Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1986 June; 79(6): 323–325.
PMCID: PMC1290338

Serum parathyroid hormone levels in the hypercalcaemia of urological malignant disease.


Serum parathyroid hormone (PTH) levels have been measured in 8 patients with hypercalcaemia associated with urological malignancy: 3 renal cell carcinomas, 2 adenocarcinomas of prostate, 2 transitional cell carcinomas of bladder and one transitional cell carcinoma of kidney. Five (63%) of these 8 patients had bone metastases. PTH was detectable in the serum of all 8 hypercalcaemic patients, but in only 2 cases was the PTH level above the normal range, and in one of these a coincidental parathyroid adenoma was found to be responsible for the hypercalcaemia. It appears that these tumours can produce a hormone-like substance with biological effects similar to PTH.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (413K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ralston S, Fogelman I, Gardner MD, Boyle IT. Hypercalcaemia and metastatic bone disease: is there a causal link? Lancet. 1982 Oct 23;2(8304):903–905. [PubMed]
  • COPE O, BARNES BA, CASTLEMAN B, MUELLER GC, ROTH SI. Vicissitudes of parathyroid surgery: trials of diagnosis and management in 51 patients with a variety of disorders. Ann Surg. 1961 Oct;154:491–508. [PubMed]
  • Chambers TJ. The pathobiology of the osteoclast. J Clin Pathol. 1985 Mar;38(3):241–252. [PMC free article] [PubMed]
  • Seyberth HW, Segre GV, Morgan JL, Sweetman BJ, Potts JT, Jr, Oates JA. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med. 1975 Dec 18;293(25):1278–1283. [PubMed]
  • Tashjian AH., Jr Role of prostaglandins in the production of hypercalcemia by tumors. Cancer Res. 1978 Nov;38(11 Pt 2):4138–4141. [PubMed]
  • Brenner DE, Harvey HA, Lipton A, Demers L. A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy. Cancer. 1982 Feb 1;49(3):556–561. [PubMed]
  • Horiuchi N, Holick MF, Potts JT, Jr, Rosenblatt M. A parathyroid hormone inhibitor in vivo: design and biological evaluation of a hormone analog. Science. 1983 Jun 3;220(4601):1053–1055. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press